Hepatic safety of leflunomide (LEF) in patients with rheumatoid arthritis: Results from the relief study

被引：0
|
作者：
Dougados, M
Larrey, DD
Solal-Celigny, R
Murray, GGD
Brin, SS
Smolen, JJ
机构：
[1] Univ Paris 05, Paris 14, France
[2] Hop St Eloi, Montpellier, France
[3] Ctr Jean Bernard, Le Mans, France
[4] Univ Edinburgh, Med Stat Unit, Edinburgh EH8 9YL, Midlothian, Scotland
[5] Lab Aventis, Paris, France
[6] Univ Vienna, Interne Abt, A-1010 Vienna, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [31] THE EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH METHOTREXATE AND LEFLUNOMIDE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    Stanislavchuk, M. A.
    Shevchuk, S. V.
    Ursol, N. B.
    [J]. RHEUMATOLOGY, 2003, 42 : 97 - 97
  • [32] Drug persistence rate of leflunomide(LEF) in rheumatoid arthritis (RA) patients treated by private practice rheumatologists in Switzerland
    Russ, WJ
    Von Kempis, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 154 - 155
  • [33] Safety and efficacy of the combination of leflunomide and etanercept in rheumatoid arthritis
    Fiocco, U.
    Vezzu, M.
    Sfriso, P.
    Cozzi, L.
    Checchetto, C.
    Ciprian, L.
    Botsios, C.
    Todesco, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 190 - 191
  • [34] A PROSPECTIVE, OBSERVATIONAL STUDY ON THE CLINICAL EFFICACY AND SAFETY OF LEFLUNOMIDE IN EGYPTIAN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: CLEAR STUDY
    Elsayed, Adel
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1672 - 1673
  • [35] Maintenance rate of leflunomide in patients with rheumatoid arthritis: Relief 1-year data.
    Dougados, M
    Emery, P
    Lemmel, EM
    de la Serna, AR
    Zerbini, CAF
    Antoine, C
    Brin, S
    van Riel, P
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S173 - S173
  • [36] Individualization of leflunomide dosing in rheumatoid arthritis patients
    Hopkins, Ashley M.
    O'Doherty, Catherine E.
    Foster, David J. R.
    Upton, Richard N.
    Proudman, Susanna M.
    Wiese, Michael D.
    [J]. PERSONALIZED MEDICINE, 2014, 11 (04) : 449 - 461
  • [37] Leflunomide in the treatment of patients with early rheumatoid arthritis-results of a prospective non-interventional study
    Kellner, Herbert
    Bornholdt, Klaus
    Hein, Gert
    [J]. CLINICAL RHEUMATOLOGY, 2010, 29 (08) : 913 - 920
  • [38] Treatment of active rheumatoid arthritis (RA) with combination therapy by adding leflunomide (LEF) in patients with an inadeguate response to methotrexate (mtx)
    Pisoni, L
    Schito, E
    De Lucia, O
    Murgo, A
    Zeni, S
    Paresce, E
    Fantini, F
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 457 - 457
  • [39] A clinical and pharmacokinetic (PK) evidence basis for the optimal use of leflunomide (LEF) in pediatric patients with juvenile rheumatoid arthritis (JRA)
    Kovacs, SJ
    Shi, J
    Silverman, E
    Prieur, A
    Simpson, K
    Stewart, J
    Strand, V
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 192 - 192
  • [40] Treatment with leflunomide slows radiographic progression of rheumatoid arthritis - Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis (vol 43, pg 495, 2000)
    Sharp, JT
    Strand, V
    Leung, H
    Hurley, F
    LoewFriedrich, I
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1345 - 1345
12345